Prospective 5-year natural history study of infantile PLA2G6-associated neurodegeneration

Allison Gregory1, Kira M Anderson1, Helena Loftus1

  • 1Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.

Insights

This study tracked developmental milestones and quality of life in children with infantile PLA2G6-associated neurodegeneration (PLAN). Physical abilities declined significantly with age, highlighting the need for clinical references and trial designs.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Infantile PLA2G6-associated neurodegeneration (PLAN) is a rare, progressive neurodegenerative disorder.
  • Understanding the natural history of developmental milestones and quality of life is crucial for managing infantile PLAN.

Purpose of the Study:

  • To prospectively characterize developmental milestone attainment and loss in children with infantile PLAN.
  • To assess disease milestone acquisition and its association with quality of life.
  • To establish disease norms for clinical reference and interventional trial design.

Main Methods:

  • A prospective, observational, longitudinal natural history study involving 40 children with infantile PLAN.
  • Analysis of developmental and disease milestones using histograms and Kaplan-Meier curves.
  • Health-related quality of life assessed using the Infant Toddler Quality of Life Questionnaire (ITQOL-97) and analyzed with mixed-effects linear regression.

Main Results:

  • Children with infantile PLAN retained some vocal and social milestones but rarely achieved walking.
  • Quality of life scores, particularly 'physical abilities,' showed significant decline with age compared to a US reference population.
  • All ITQOL-97 domains, except 'general behavior,' differed significantly from the reference population.

Conclusions:

  • This study provides the first prospective characterization of developmental and disease milestones in infantile PLAN.
  • Longitudinal quality of life data reveal significant age-related changes, especially in physical abilities.
  • The findings offer essential disease norms for clinical practice and future therapeutic trial development.
Abstract

Related Concept Videos